Tag: Avibela

As Medicines360 commemorates World Contraception Day 2019, we recognize the work we’ve done and the work we have left to do. Too many women in the U.S. and across the globe still have difficulty accessing the full range of contraceptive options to live their lives on their own terms. In addition to improving contraceptive access […]

Medicines360 is delighted to announce that Margot Fahnestock has joined our team as Vice President of Strategic Development.  Margot will be responsible for planning, organizing, and implementing all of our high-impact strategic programming and fundraising efforts both in the U.S. and globally. Before Medicines360, Margot served as a Program Officer in the William and Flora […]

Medicines360 is excited to announce that Avibela™, our 52 mg levonorgestrel intrauterine device (IUD), has launched in Zambia! AVIBELA is the first hormonal IUD registered in Zambia. AVIBELA is not indicated for use in the United States. Through the global FP2020 initiative, the Zambian government has committed to improving sustainable access to family planning. In alignment […]

Federally Qualified Health Centers (FQHCs) are community-based providers that exist to meet patients where they live and provide the primary care services they need. With approximately 12,000 service delivery sites located across the country. FQHCs serve a large number of both insured and uninsured patients. FQHCs have sliding fee scales for uninsured patients to make […]